Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Unloaded Minds - How Prolonged Unloading Shapes Human Performance in Lunar Gravity (UnloadedMinds)

20 maggio 2026 aggiornato da: Rodrigo Fernandez Gonzalo, Karolinska Institutet

During spaceflight and lunar missions, reduced gravitational loading causes the muscles and nervous system to decondition rapidly. While muscle wasting is well documented, much less is known about how the brain and spinal cord adapt to the absence of normal mechanical loading - and how these central changes interact with muscle deterioration to impair movement control.

This study investigates how two weeks of simulated lower limb unloading affects the brain's movement programs (motor engrams), the functional connection between nerves and muscles, and overall movement quality. Healthy participants undergo 14 days of Unilateral Lower Limb Suspension (ULLS), a model in which one leg is kept unloaded using a raised shoe and crutches while the other leg functions normally. After the unloading period, participants travel to Bordeaux, France, where they walk on a treadmill for the first time - in lunar gravity - during a parabolic flight.

Before and after the unloading period, participants are assessed with MRI (muscle size), force plate tests (jump performance and balance), nerve stimulation (number of functional motor units), and treadmill gait analysis combining brain activity (EEG), muscle activity (EMG), joint movement, and plantar pressure measurements. The same gait analysis is repeated during the parabolic flight under lunar gravity (0.16G).

The results will shed light on how the brain and muscles adapt to disuse and reactivate under partial gravity - with direct relevance to astronaut safety and rehabilitation, as well as clinical conditions involving prolonged limb immobilization.

Panoramica dello studio

Descrizione dettagliata

The study combines two spaceflight analogues in sequence: a 14-day Unilateral Lower Limb Suspension (ULLS) protocol followed by a parabolic flight campaign simulating lunar gravity (0.16G). This design allows investigation of both the neuromuscular consequences of unloading and the acute reactivation of the system upon first weight-bearing locomotion under partial gravity.

During ULLS, participants keep one lower limb (randomized in a counterbalanced manner) unloaded continuously using a shoe with a 10-cm thick sole and short-length crutches with forearm support. The suspended limb remains in a near-straight position and swings freely from the hip during all upright and ambulatory activity. Compliance is verified daily via telephone interviews, continuous midcalf skin temperature monitoring, and accelerometer data. Fragmin 5000 IU is administered subcutaneously once daily throughout the ULLS period as thromboprophylaxis.

Following the 14-day ULLS period, participants travel to Bordeaux where they continue the ULLS protocol until initiating the first steps on a treadmill during the lunar gravity phases of a parabolic flight. Each participant is allocated 15 parabolas (~20 seconds of 0.16G each): parabolas 1-8 at 3 km/h and parabolas 9-15 at 5 km/h.

Gait analysis is performed on a treadmill at 3 and 5 km/h at baseline (pre-ULLS) and during the parabolic flight. Kinematic data (knee and ankle joint angles) are recorded bilaterally using 2D electronic goniometers (Biometrics, 500 Hz) in the frontal and sagittal planes. Ground reaction forces and spatiotemporal parameters (step and stride length, cadence, step width, gait cycle duration and variability) are recorded using plantar pressure insoles (200 Hz). All signals are synchronized to allow left/right (loaded/unloaded) differentiation.

EEG is recorded during all gait sessions using a 64-channel cap (EasyCap GmbH) with electrodes placed per the international 10-20 system (reference: FCz; ground: AFz). Data are processed in BrainVision Analyzer 2.2 using visual inspection, automated artefact rejection (gradient threshold >60 µV), ICA, and bandpass filtering (0.5-40 Hz). Cortical current density in the motor cortex (M1, Brodmann area 4) is computed using the sLORETA module.

Surface EMG is recorded continuously during gait from eight bilateral lower limb muscles (rectus femoris, lateral hamstrings, gastrocnemius lateralis, tibialis anterior) using a wireless system (Delsys, USA; 2000 Hz), with electrode placement per SENIAM guidelines. Data are bandpass filtered (12-500 Hz), full-wave rectified, and lowpass filtered (7 Hz) to derive linear activation envelopes.

Motor Unit Number Estimation (MUNE) is performed using the MScanFit method, which applies incremental electrical stimuli to the peripheral nerve at 0.6-second intervals across varying intensities, recording the full stimulus-response curve via surface EMG to estimate the number of functional motor units innervating lower leg muscles.

MRI is performed before and after ULLS using a 3-Tesla system. T2-weighted images are acquired to quantify thigh and calf muscle volumes bilaterally. Participants rest supine for ~30 minutes prior to each scan to minimize fluid shift artefacts.

Neuromuscular performance and balance are assessed before ULLS and immediately after the parabolic flight using dual force plates (MuscleLab, 200 Hz). Measures include countermovement jump height, peak power, rate of force development, and centre-of-pressure-based postural stability variables.

Statistical Analysis Data will be assessed for normality using the Shapiro-Wilk test. Continuous outcome variables will be analysed using linear mixed-effects models (LMMs) with Time (pre, post), Leg (unloaded, control), and their interaction (Time × Leg) as fixed effects, and Subject as a random intercept. This approach appropriately handles the repeated-measures, within-subject structure of the data and accommodates missing observations without listwise deletion. Degrees of freedom will be estimated using the Satterthwaite approximation. Where a significant interaction is detected, pairwise post-hoc comparisons will be performed with Bonferroni correction. Effect sizes will be reported as Cohen's d.

For the parabolic flight gait analysis, outcomes recorded at 1G (pre-ULLS) and 0.16G (during flight) will be compared using LMMs with Gravity Condition (1G, 0.16G), Leg (unloaded, control), and Speed (3 km/h, 5 km/h) as fixed effects, and Subject as a random intercept.

Associations between central (EEG-derived cortical current density, MUNE) and peripheral (muscle volume, jump performance, EMG) outcomes will be examined using Pearson or Spearman correlation coefficients, depending on data distribution.

A sample size of 12 participants provides 95% power to detect a moderate effect size (f = 0.6) at a significance level of α = 0.05 for a within-subject design comparing outcomes across gravity conditions (G*Power; λ = 17.3, critical F = 4.85). Twenty-four participants will be recruited to account for potential dropouts (including motion sickness during the parabolic flight, which may be a common, impossible-to-predict cause of dropout) and ensure the required sample is available for analysis. Statistical analyses will be performed in R (R Foundation for Statistical Computing). The significance threshold is set at p < 0.05.

Tipo di studio

Interventistico

Iscrizione (Stimato)

24

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Stockholm County
      • Huddinge, Stockholm County, Svezia, 14152
        • Reclutamento
        • Karolinska Institutet
        • Contatto:
          • Lars Frelin, Facility manager
          • Numero di telefono: +46852483632
          • Email: lars.frelin@ki.se

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Descrizione

Inclusion Criteria:

- 18-60 years of age, willing to participate

Exclusion Criteria:

  • high activity level according to the GLTEQ
  • contraindications to exercise
  • pregnancy
  • contraindications to MRI
  • active cardiovascular disease
  • cerebrovascular disease including previous stroke
  • aneurysm (large vessels or intracranial)
  • pulmonary disease including pulmonary hypertension or COPD
  • metabolic diseases (including: hyper/hypoparathyroidism, hyper/hypothyroidism, Cushing's disease, type 1 or type 2 diabetes)
  • active inflammatory bowel disease
  • kidney disease
  • malignancy
  • recent steroid treatment (within the past 6 months), or hormone replacement therapy
  • coagulation disorders
  • musculoskeletal or neurological diseases
  • diseases requiring long-term medication, including statin therapy
  • smoking

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: ULLS
There is only one arm, where one leg is the experimental, unloaded leg, and the other one is the control (loaded) leg
Unilateral Lower Limb Suspension (ULLS) is a validated spaceflight analog for the lower limbs, which mimics unloading specifically in the lower limbs 3. In ULLS, participants wear a shoe with ~100 mm elevated sole and use short-length crutches aided by a hand grip and forearm support distal to the elbow. This allows the contralateral lower limb to remain unloaded in a straight position and move passively at the hip. The ULLS model specifically targets skeletal muscle unloading in the lower limb with no or minor systemic deconditioning, and it imposes minimal restrictions on participants' daily activities. A key advantage of ULLS is that the contralateral, weight-bearing limb provides a valid inherent control accounting for individual factors such as nutrition, genetics, and lifestyle.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Muscle volume
Lasso di tempo: Three days before the initiation of the ULLS intervention and at day 15 of unloading, for both thigh and calf muscles bilaterally.
Three days before the initiation of the ULLS intervention, and at day 15 of unloading, all participants will undergo an MRI scan to assess thigh and calf muscle size. Muscle volume will be evaluated using cross-sectional T2-weighted images acquired on a 3-Tesla MR system. Anatomical landmarks and standardized procedures will ensure that the same segment is scanned at both time points. Participants will rest in a supine position for approximately 30 minutes prior to each scan to minimize measurement interference caused by fluid shift. Images will be analysed using manual segmentation to delineate individual muscle boundaries in each cross-sectional slice; muscle volume is then calculated by summing the cross-sectional areas of the target muscles across all slices and multiplying by slice thickness.
Three days before the initiation of the ULLS intervention and at day 15 of unloading, for both thigh and calf muscles bilaterally.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Gait analysis
Lasso di tempo: Gait analysis will be performed three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight
Gait analysis will be performed before the ULLS phase and during the lunar gravity phases of a parabolic flight at the two selected gait speeds of 3 km/h and 5 km/h. Kinematic parameters such as knee and ankle joint angles are recorded using 2-dimensional electronic goniometers (Biometrics). Kinematic data will be recorded in the frontal and sagittal plane at a sampling frequency of 500 Hz. Kinetic and spatiotemporal parameters like the force distribution are recorded using pressure insoles with a sampling frequency of 200 Hz. Spatiotemporal parameters are crucial indicators of gait stability and overall mobility. They include variables such as step length, stride length, cadence, step width, and gait cycle duration and their variability.
Gait analysis will be performed three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight
Electroencephalogram
Lasso di tempo: Three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight, during the gait analysis tests.
The data is recorded using a 64-channel electroencephalography (EEG) cap adapted to the size of the head. The electrodes are arranged in the international 10-20 system around the motor cortex. Electrode FCz is used as a reference, AFz as ground. The EEG cap, which is fixed with a chin strap to prevent displacement, is permeable to air to ensure appropriate air ventilation during exercise. The distances between the electrodes are approx. 5 cm to prevent a possible false signal due to salt bridges caused by perspiration. Each electrode is filled with SuperViscTM electrode gel (EasyCap GmbH, Herrsching, Germany) for signal transmission. The use of active EEG electrodes developed by Brain Products (Gilching, Germany) allows the recording of electrocortical activity during exercise without movement artefacts.
Three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight, during the gait analysis tests.
Electromyography
Lasso di tempo: Three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight, during the gait analysis tests.
Surface EMG activity will be continuously recorded for the following 8 muscles of the left and right lower limbs: rectus femoris (RFL and RFR), lateral hamstrings (HL and HR), gastrocnemius lateralis (GASL and GASR), and tibialis anterior (TAL and TAR). These muscles are activated by the Central Nervous System (CNS) to produce the gait. The EMG signals will be collected using a commercial surface wireless EMG system (Delsys, USA).
Three-to-five days before the ULLS phase and during the lunar gravity phases of a parabolic flight, during the gait analysis tests.
Muscle function and balance
Lasso di tempo: Three days before initiation of ULLS and immediately after the parabolic flight.
Muscle function will be assessed by a standardized countermovement jump on force plates (MuscleLab, Norway). Balance will be assessed by a sway test where participants will balance on one leg with their eyes closed and eyes open, this is also done on force plates.
Three days before initiation of ULLS and immediately after the parabolic flight.
Motor unit number estimation
Lasso di tempo: Three days before initiation of ULLS and immediately after the parabolic flight.
Motor unit number estimation (MUNE) test that assesses how many motor units are functioning in a muscle. It starts with placing surface electrodes on the skin to record electrical activity from the target muscle. A mild electrical stimulus is applied to the nerve supplying the muscle, and the response (motor unit potential) is measured. By gradually increasing the stimulus and analyzing the size and number of responses, an estimate of the total number of motor units is calculated.
Three days before initiation of ULLS and immediately after the parabolic flight.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 maggio 2026

Completamento primario (Stimato)

31 maggio 2028

Completamento dello studio (Stimato)

31 marzo 2029

Date di iscrizione allo studio

Primo inviato

13 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

20 maggio 2026

Primo Inserito (Effettivo)

26 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

26 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

20 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2025-02981-01 - UnloadedMinds

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi